Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Role of toll-like receptor 2 in ischemic demyelination and oligodendrocyte death.
Defining Quality of Life Levels to Enhance Clinical Interpretation in Multiple Sclerosis: Application of a Novel Clustering Method.
Swimming exercise ameliorates multiple sclerosis-induced impairment of short-term memory by suppressing apoptosis in the hippocampus of rats.
Epstein-barr virus in the central nervous system and cervical lymph node of a patient with primary progressive multiple sclerosis.
Synchrony analysis: application in early diagnosis, staging and prognosis of multiple sclerosis.
Functional outcomes associated with expiratory muscle strength training: Narrative review.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Walking while talking in patients with multiple sclerosis: The impact of specific cognitive loads.
Ischemic skin necrosis caused by glatiramer acetate in multiple sclerosis patients.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Effect of high-dose 1.25 dihydroxyvitamin D3 on remyelination in the cuprizone model.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Dopamine favors expansion of glucocorticoid-resistant IL-17-producing T cells in multiple sclerosis.
Stabilometric assessment of context dependent balance recovery in persons with multiple sclerosis: a randomized controlled study.
Epstein-Barr virus in multiple sclerosis.
Multiple sclerosis is primarily a neurodegenerative disease.
Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis.
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
TRPM2 Cation Channels Modulate T Cell Effector Functions and Contribute to Autoimmune CNS Inflammation.
Confounding Parameters in Pre-clinical Assessment of Blood-brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States.
T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Redox processes in neurodegenerative disease involving reactive oxygen species.
Prediction of disability progression in fingolimod-treated patients.
A chemical proteomic atlas of brain serine hydrolases identifies cell type-specific pathways regulating neuroinflammation.
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy.
Pages
« first
‹ previous
…
423
424
425
426
427
428
429
430
431
…
next ›
last »